Search

Your search keyword '"Pallais, J. Carl"' showing total 143 results

Search Constraints

Start Over You searched for: Author "Pallais, J. Carl" Remove constraint Author: "Pallais, J. Carl"
143 results on '"Pallais, J. Carl"'

Search Results

1. Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities

2. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

3. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

4. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

5. De novo variants in DENND5B cause a neurodevelopmental disorder

6. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

7. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

8. Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly

9. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

10. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

11. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

12. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

13. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

14. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

15. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

16. De novo variants in DENND5B cause a neurodevelopmental disorder

17. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

18. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

19. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

21. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

23. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

24. High-dimensional immunophenotyping reveals immune cell aberrations in patients with undiagnosed inflammatory and autoimmune diseases

26. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

27. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

28. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

29. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

30. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

32. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma

33. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

34. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

35. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

36. One is the loneliest number: genotypic matchmaking using the electronic health record

38. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

39. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

45. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

47. The Game Is Afoot

49. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

Catalog

Books, media, physical & digital resources